Patents by Inventor Yuchi Hwang

Yuchi Hwang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Responsiveness to Therapy for Liver Disorders
    Publication number: 20100028868
    Abstract: Sets of nucleic acids and methods for predicting a subject's responsiveness to therapy for liver disorders.
    Type: Application
    Filed: July 29, 2008
    Publication date: February 4, 2010
    Inventors: Yuchi Hwang, Kuang-Den Chen, Chingwei Chang, Jui-Lin Chen, Ding-Shinn Chen, Pei-Jer Chen, Ming-Yang Lai
  • Responsiveness to therapy for liver disorders
    Patent number: 7405043
    Abstract: Sets of nucleic acids and methods for predicting a subject's responsiveness to therapy for liver disorders.
    Type: Grant
    Filed: June 29, 2004
    Date of Patent: July 29, 2008
    Assignee: Vita Genomics, Inc.
    Inventors: Yuchi Hwang, Kuang-Den Chen, Chingwei Chang, Jui-Lin Chen, Ding-Shinn Chen, Pei-Jer Chen, Ming-Yang Lai
  • Method for detecting a propensity of an individual to respond effectively to treatment of interferon-? and ribavirin combined therapy
    Patent number: 7108978
    Abstract: It is provided isolated polynucleotides that include sequences from genomic region around the gene CD 81. The polynucleotides include polymorphisms associated with treatment response of HCV patients to interferon-? and ribavirin combined therapy and are useful as the probes in screening for patients who will response to interferon-? and ribavirin combined therapy. It is further provided linkage disequilibrium structure of the CD81 gene and haplotype information within a particular LD block, which can be used for prediction of the treatment outcome of the interferon-? and ribavirin combined therapy on HCV patients.
    Type: Grant
    Filed: July 15, 2003
    Date of Patent: September 19, 2006
    Assignee: Vita Genomics, Inc.
    Inventors: Jui-Lin Chen, Yuchi Hwang, Min-Pey Ding, Wen-Pi Chu, Shu-Ching Wang, Kuei-Ling Belinda Chen, Wan-Lin Yao, Kuang-Den Chen, Ding-Shinn Chen, Pei-Jer Chen, Ming-Yang Lai
  • Responsiveness to therapy for liver disorders
    Publication number: 20050288497
    Abstract: Sets of nucleic acids and methods for predicting a subject's responsiveness to therapy for liver disorders.
    Type: Application
    Filed: June 29, 2004
    Publication date: December 29, 2005
    Applicant: Vita Genomics, Inc.
    Inventors: Yuchi Hwang, Kuang-Den Chen, Chingwei Chang, Jui-Lin Chen, Ding-Shinn Chen, Pei-Jer Chen, Ming-Yang Lai
  • Method for detecting a propensity of an individual to response effectively to treatment of interferon-alpha and ribavirin combined therapy
    Publication number: 20050014159
    Abstract: It is provided isolated polynucleotides that include sequences from genomic region around the gene CD 81. The polynucleotides include polymorphisms associated with treatment response of HCV patients to interferon-? and ribavirin combined therapy and are useful as the probes in screening for patients who will response to interferon-? and ribavirin combined therapy. It is further provided linkage disequilibrium structure of the CD81 gene and haplotype information within a particular LD block, which can be used for prediction of the treatment outcome of the interferon-? and ribavirin combined therapy on HCV patients.
    Type: Application
    Filed: July 15, 2003
    Publication date: January 20, 2005
    Inventors: Jui-Lin Chen, Yuchi Hwang, Min-Pey Ding, Wen-Pi Chu, Shu-Ching Wang, Kuei-Ling Chen, Wan-Lin Yao, Kuang-Den Chen, Ding-Shinn Chen, Pei-Jer Chen, Ming-Yang Lai
  • Conditional touchdown multiplex polymerase chain reaction
    Publication number: 20040241655
    Abstract: A high-throughput and cost-effective method for simultaneous amplification of target DNA sequences with high fidelity and workable rate is achieved by a two-stage amplification incorporating multiplex PCR with conditional touchdown strategies. This improved multiplex PCR comprises a simultaneous PCR and a specific PCR, and either one or both of the amplification steps are performed with a touchdown strategy, of which loose touchdown strategy is applied with a temperature lower than the optimized annealing temperature, and stringent touchdown strategy is applied with a temperature higher than the optimized annealing temperature.
    Type: Application
    Filed: May 29, 2003
    Publication date: December 2, 2004
    Inventors: Yuchi Hwang, Yun-Yun Cheng